Skip to main content

Table 4 Associations with stratification by bilateral cases

From: Nuclear receptor coregulator SNP discovery and impact on breast cancer risk

SNP

Genotypes

Cases

Controls

OR

95% CI

P

Cases bilateral

SRC-1

CC (%)

106 (93.8)

1432 (94.9)

1

  

Rs1804645

CT (%)

6 (5.3)

77 (5.1)

1.05

0.44-2.47

0.906

P1272S

TT (%)

1 (0.9)

0 (0.0)

-

-

-

  

[CT + TT]<-> [CC]

1.22

0.55-2.73

0.613

SRC-3

CC (%)

95 (86.4)

1330 (89.3)

1

  

rs6094752

CT (%)

14 (12.7)

152 (10.2)

1.29

0.72-2.32

0.393

C218R

TT (%)

1 (0.9)

8 (0.5)

1.75

0.22-14.14

0.595

  

[CT + TT]<-> [CC]

1.31

0.74-2.32

0.347

SRC-3

GG (%)

88 (80.0)

1207 (80.3)

1

  

Rs2230782

GC (%)

22 (20.0)

272 (18.1)

1.11

0.68-1.80

0.675

Q586H

CC (%)

0 (0.7)

24 (1.6)

0.28

0.017-4.62

0.186

  

[CC]<-> [GG + CT]

1.02

0.63-1.65

0.938

SRC-3

AA (%)

89 (80.2)

1240 (82.2)

1

  

rs2076546

AG (%)

21 (18.9)

249 (16.5)

1.17

0.72-1.93

0.522

T960T

GG (%)

1 (0.9)

20 (1.3)

0.69

0.09-5.25

0.724

  

[AG + GG]<-> [AA]

1.14

0.70-1.85

0.597

SMRT

GG (%)

79 (72.5)

1004 (67.6)

1

  

rs2229840

AG (%)

27 (24.8)

423 (28.5)

0.81

0.52-1.27

0.363

A1706T

AA (%)

3 (2.7)

57 (3.9)

0.67

0.20-2.18

0.502

  

[AG + GG]<-> [AA]

0.79

0.51-1.23

0.298

  1. Odds ratios (OR) with 95% confidence intervals (95% CI) and P-values.